Sign up for the QMED & MD+DI Daily newsletter.
Reuters News reports that a Cleveland Clinic study shows that patients who had a brand of implantable cardioverter-defibrillator (ICD) recalled last year are at no greater risk of death than patients who have other ICD brands implanted. The patients were monitored from 1996 to 2004. During that time, 31% of those with a recalled device died, compared to 34% of those with other brands.
March 15, 2006
1 Min Read
.svg?width=850&auto=webp&quality=95&format=jpg&disable=upscale "Some Relief for Patients with Recalled ICDs")
This is certainly reassuring to those affected by the recalls from Guidant Corp. and Medtronic, Inc. It also shows that Guidant's difficulties with disclosing its devices' failures may have created more problems than they solved.
You May Also Like
